Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

An anthrax lethal factor mutant that is defective at causing pyroptosis retains proapoptotic activity.

Ngai S, Batty S, Liao KC, Mogridge J.

FEBS J. 2010 Jan;277(1):119-27. doi: 10.1111/j.1742-4658.2009.07458.x.

2.

Anthrax toxin.

Bhatnagar R, Batra S.

Crit Rev Microbiol. 2001;27(3):167-200. Review.

PMID:
11596878
3.

Anthrax lethal toxin: a weapon of multisystem destruction.

Agrawal A, Pulendran B.

Cell Mol Life Sci. 2004 Nov;61(22):2859-65. Review.

PMID:
15558214
4.

Anthrax lethal toxin and the induction of CD4 T cell immunity.

Ascough S, Ingram RJ, Altmann DM.

Toxins (Basel). 2012 Oct;4(10):878-99. doi: 10.3390/toxins4100878. Review.

5.

The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.

Tonello F, Montecucco C.

Mol Aspects Med. 2009 Dec;30(6):431-8. doi: 10.1016/j.mam.2009.07.006. Review.

PMID:
19665472
6.

Anthrax toxin: a tripartite lethal combination.

Ascenzi P, Visca P, Ippolito G, Spallarossa A, Bolognesi M, Montecucco C.

FEBS Lett. 2002 Nov 20;531(3):384-8. Review.

7.

Anthrax toxins: A paradigm of bacterial immune suppression.

Baldari CT, Tonello F, Paccani SR, Montecucco C.

Trends Immunol. 2006 Sep;27(9):434-40. Review.

PMID:
16861036
8.

Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity.

Fukao T.

Lancet Infect Dis. 2004 Mar;4(3):166-70. Review.

PMID:
14998502
9.

Anthrax lethal factor inhibitors as potential countermeasure of the infection.

Kumar BV, Malik S, Grandhi P, Dayam R, Sarma JA.

Curr Top Med Chem. 2014;14(17):1977-89. Review.

PMID:
25262802
10.

The effects of anthrax lethal toxin on host barrier function.

Xie T, Auth RD, Frucht DM.

Toxins (Basel). 2011 Jun;3(6):591-607. doi: 10.3390/toxins3060591. Review.

11.

New aspects of the infection mechanisms of Bacillus anthracis.

Zakowska D, Bartoszcze M, Niemcewicz M, Bielawska-Drózd A, Kocik J.

Ann Agric Environ Med. 2012;19(4):613-8. Review.

12.

Anthrax toxin: pathologic effects on the cardiovascular system.

Golden HB, Watson LE, Lal H, Verma SK, Foster DM, Kuo SR, Sharma A, Frankel A, Dostal DE.

Front Biosci (Landmark Ed). 2009 Jan 1;14:2335-57. Review.

PMID:
19273204
13.

Membrane translocation by anthrax toxin.

Collier RJ.

Mol Aspects Med. 2009 Dec;30(6):413-22. doi: 10.1016/j.mam.2009.06.003. Review.

14.

Manipulation of host signalling pathways by anthrax toxins.

Turk BE.

Biochem J. 2007 Mar 15;402(3):405-17. Review.

PMID:
17313374
15.

[Molecular model of anthrax toxin translocation into target-cells].

Noskov AN.

Bioorg Khim. 2014 Jul-Aug;40(4):399-404. Review. Russian.

PMID:
25898749
16.

Anthrax toxins: a weapon to systematically dismantle the host immune defenses.

Tournier JN, Rossi Paccani S, Quesnel-Hellmann A, Baldari CT.

Mol Aspects Med. 2009 Dec;30(6):456-66. doi: 10.1016/j.mam.2009.06.002. Review.

PMID:
19560486
17.

Consequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxin.

Bromberg-White J, Lee CS, Duesbery N.

Toxins (Basel). 2010 May;2(5):1038-53. doi: 10.3390/toxins2051038. Review.

18.

Cytoskeleton as an emerging target of anthrax toxins.

Trescos Y, Tournier JN.

Toxins (Basel). 2012 Feb;4(2):83-97. doi: 10.3390/toxins4020083. Review.

19.

Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy.

Sherer K, Li Y, Cui X, Eichacker PQ.

Am J Respir Crit Care Med. 2007 Feb 1;175(3):211-21. Review.

20.

T cell targeting by anthrax toxins: two faces of the same coin.

Paccani SR, Baldari CT.

Toxins (Basel). 2011 Jun;3(6):660-71. doi: 10.3390/toxins3060660. Review.

Items per page

Supplemental Content

Support Center